The present invention relates to a novel method of treating
male infertility such as, for example, idiopathic asthenospermia. In one aspect the present invention relates to the treatment or prevention of
male infertility through the administration of a composition containing ubiquinone, ubiquinol or both, and optionally, a member chosen from the group consisting of a
reducing agent, a solubilizer, an emulsifier, a surfactant, a
triglyceride, an oil, a fat, a lipid, a
phospholipid, a
carbohydrate, an
antioxidant, a
carnitine,
creatine, an herbal extract, a
vitamin, a coenzyme, a mineral, an
electrolyte, a pharmaceutical, a water, a carrier, an
excipient, and any combination thereof.